Potential of nitroimidazoles as markers of hypoxia in heart.
Rumsey
W L
WL
Bristol-Myers Squibb Pharmaceutical Research Institute, New Brunswick, NJ 08903.
Patel
B
B
Kuczynski
B
B
Narra
R K
RK
Chan
Y W
YW
Linder
K E
KE
Cyr
J
J
Raju
N
N
Ramalingam
K
K
Nunn
A D
AD
D000818:Animals; D015415:Biomarkers; D004285:Dogs; D000860:Hypoxia / Q000175:diagnosis / Q000378:metabolism*; D066298:In Vitro Techniques; D009206:Myocardium / Q000378:metabolism*; D009593:Nitroimidazoles / Q000493:pharmacokinetics*; D015609:Organotechnetium Compounds / Q000493:pharmacokinetics; D010101:Oxygen Consumption; D051381:Rats; D017207:Rats, Sprague-Dawley
D015415:Biomarkers; D009593:Nitroimidazoles; D015609:Organotechnetium Compounds; C082027:BMS 181321